1. Home
  2. AAME vs ATNM Comparison

AAME vs ATNM Comparison

Compare AAME & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic American Corporation

AAME

Atlantic American Corporation

N/A

Current Price

$1.05

Market Cap

34.3M

Sector

Finance

ML Signal

N/A

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

N/A

Current Price

$1.43

Market Cap

31.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AAME
ATNM
Founded
1968
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.3M
31.4M
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
AAME
ATNM
Price
$1.05
$1.43
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $4.00
AVG Volume (30 Days)
★ 888.9K
238.5K
Earning Date
11-17-2026
11-13-2026
Dividend Yield
★ 1.91%
N/A
EPS Growth
★ 221.74
14.17
EPS
0.28
★ 0.71
Revenue
★ $210,440,000.00
$90,000.00
Revenue This Year
N/A
$38,788.89
Revenue Next Year
N/A
N/A
P/E Ratio
$3.89
★ $2.00
Revenue Growth
★ 11.80
11.11
52 Week Low
$1.03
$0.74
52 Week High
$3.24
$1.72

Technical Indicators

Market Signals
Indicator
AAME
ATNM
Relative Strength Index (RSI) 41.54 59.32
Support Level $1.03 $0.91
Resistance Level $1.66 $1.66
Average True Range (ATR) 0.14 0.15
MACD -0.02 0.01
Stochastic Oscillator 8.85 70.42

Price Performance

Historical Comparison
AAME
ATNM

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

Share on Social Networks: